(Q38232197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

multiple drug resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jesús Rodríguez-Baño

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

4

Stephan Harbarth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Esther Bettiol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Dolores Del Toro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marc J Bonten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

COMBACTE consortium

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

757-771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

Society's failure to protect a precious resource: antibiotics

10 March 2020

cites work

1 reference

The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia

21 January 2018

1 reference

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

Priority actions to fight antibiotic resistance: results of an international meeting

21 January 2018

1 reference

Choosing optimal antimicrobial therapies

21 January 2018

1 reference

Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae

21 January 2018

1 reference

Fourteen years in resistance

21 January 2018

1 reference

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection.

21 January 2018

1 reference

Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants.

21 January 2018

1 reference

Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model

21 January 2018

1 reference

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

21 January 2018

1 reference

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

21 January 2018

1 reference

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

21 January 2018

1 reference

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

21 January 2018

1 reference

Treatment of resistant bacterial infections in children: thinking inside and outside the box.

21 January 2018

1 reference

Frequency of the off-label use of antibiotics in clinical practice: a systematic review

21 January 2018

1 reference

Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries

21 January 2018

1 reference

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens

21 January 2018

1 reference

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

21 January 2018

1 reference

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

21 January 2018

1 reference

Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections

21 January 2018

1 reference

Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design

21 January 2018

1 reference

Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections

21 January 2018

1 reference

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

21 January 2018

1 reference

Daptomycin or vancomycin for methicillin-resistant Staphylococcus aureus with a vancomycin minimum inhibitory concentration >1 μg/L.

21 January 2018

1 reference

Early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time?

21 January 2018

1 reference

Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital.

21 January 2018

1 reference

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies

21 January 2018

1 reference

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

21 January 2018

1 reference

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

21 January 2018

1 reference

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

21 January 2018

1 reference

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

21 January 2018

1 reference

The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae

21 January 2018

1 reference

Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis

21 January 2018

1 reference

Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli

21 January 2018

1 reference

High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.

21 January 2018

1 reference

Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters

21 January 2018

1 reference

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.

21 January 2018

1 reference

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

21 January 2018

1 reference

21 January 2018

1 reference

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

21 January 2018

1 reference

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

21 January 2018

1 reference

Overadjustment bias and unnecessary adjustment in epidemiologic studies

21 January 2018

1 reference

Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain

21 January 2018

1 reference

Multivariable Analysis: A Primer for Readers of Medical Research

21 January 2018

1 reference

Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections

21 January 2018

1 reference

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

21 January 2018

1 reference

Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

21 January 2018

1 reference

An overview of the objectives of and the approaches to propensity score analyses

21 January 2018

1 reference

Estimating the impact of healthcare-associated infections on length of stay and costs

21 January 2018

1 reference

A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients

21 January 2018

1 reference

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

21 January 2018

1 reference

Year in review 2010: Critical Care--Infection

21 January 2018

1 reference

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

21 January 2018

1 reference

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

21 January 2018

1 reference

Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock

21 January 2018

1 reference

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

21 January 2018

1 reference

Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies

21 January 2018

1 reference

Imipenem underdosing as a cause of persistent neutropenic fever?

21 January 2018

1 reference

Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis

21 January 2018

1 reference

High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function

21 January 2018

1 reference

Year in review 2011: Critical Care - infection

21 January 2018

1 reference

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

21 January 2018

1 reference

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.

21 January 2018

1 reference

Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.

21 January 2018

1 reference

Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors

21 January 2018

1 reference

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC inf

21 January 2018

1 reference

Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial

21 January 2018

1 reference

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

21 January 2018

1 reference

Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial

21 January 2018

1 reference

Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia

21 January 2018

1 reference

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia

21 January 2018

1 reference

Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial

21 January 2018

1 reference

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

21 January 2018

1 reference

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial

21 January 2018

1 reference

Adaptive trial designs: a review of barriers and opportunities

21 January 2018

1 reference

Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes

21 January 2018

1 reference

Registration of observational studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.14.35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25046523%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference